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Human La autoantigen has been shown to influence
internal initiation of translation of hepatitis C virus
(HCV) RNA. Previously, we have demonstrated that,
among the three RRMs of La protein, the RRM2 interacts
with HCV internal ribosome entry site (IRES) around the
GCAC motif near the initiator AUG present in the stem
region of stem-loop IV (SL IV) (Pudi, R., Abhiman, S.,
Srinivasan, N., and Das S. (2003) J. Biol. Chem. 278, 12231–
12240). Here, we have demonstrated that the mutations in
the GCAC motif, which altered the binding to RRM2, had
drastic effect on HCV IRES-mediated translation, both in
vitro and in vivo. The results indicated that the primary
sequence of the stem region of SL IV plays an important
role in mediating internal initiation. Furthermore, we
have shown that the mutations also altered the ability to
bind to ribosomal protein S5 (p25), through which 40 S
ribosomal subunit is known to contact the HCV IRES
RNA. Interestingly, binding of La protein to SL IV region
induced significant changes in the circular dichroism
spectra of the HCV RNA indicating conformational alter-
ations that might assist correct positioning of the initia-
tion complex. Finally, the ribosome assembly analysis us-
ing sucrose gradient centrifugation implied that the
mutations within SL IV of HCV IRES impair the forma-
tion of functional ribosomal complexes. These observa-
tions strongly support the hypothesis that La protein
binding near the initiator AUG facilitates the interactions
with ribosomal protein S5 and 48 S ribosomal assembly
and influences the formation of functional initiation com-
plex on the HCV IRES RNA to mediate efficient internal
initiation of translation.
Translation of hepatitis C virus (HCV)1 is mediated by an
internal ribosome entry site (IRES) located mostly within the
5-untranslated region (UTR) and extending a few nucleotides
into the open reading frame (1–5). HCV 5-UTR is highly con-
served and folds into a complex secondary structure comprising
four major structural domains (I–IV) and a pseudoknot in the
vicinity of the initiator AUG codon (6, 7). The cis-elements
promote assembly of initiation complex independent of the
5-end and thus mediate internal initiation of translation in a
cap-independent manner (7). Domain I is not a part of IRES
and most likely is involved in RNA replication, whereas do-
mains II and III are complex and consist of multiple stem-loops
and bulge-loops. Even minor mutations in domains II and III
substantially reduce IRES activity, but this could in most cases
be regained by compensatory second site mutations that re-
stored secondary structure. Highly conserved residues are of-
ten unpaired and may thus be able to interact with the com-
ponents of the translation apparatus. Domain IV consists of a
stem-loop that contains initiator AUG codon and has been
shown to play a key role in regulating the initiation of trans-
lation of the HCV RNA (5, 8–10). It appears from earlier
reports that both the sequence and stability of the domain IV
stem might control efficiency of HCV IRES translation (11, 12).
These observations have led to a model for IRES function in
which the structural elements in the IRES act as a scaffold that
orients the potential binding sites in such a way that their
interactions with initiation factors and ribosomes lead to as-
sembly of functional ribosomal initiation complexes (13).
HCV IRES binds to the 40 S ribosomal subunit specifically
and stably even in the absence of any initiation factors. Addi-
tion of eIF2/GTP/Met-tRNAi is sufficient for 40 S subunit to
lock onto initiator AUG (13). eIF3, though not essential for the
formation of 48 S complex formation, it has been shown to bind
to the apical half of domain III and is likely to be a constituent
of the 48 S-IRES complex in vivo (14, 15). 48 S complex forma-
tion on HCV IRES has no requirement for eIF4A, 4B, 4E, 4G,
or for ATP hydrolysis (14–16). Because the viral 5-UTR forms
a binary complex with the 40 S ribosomal subunit in the ab-
sence of any canonical or non-canonical initiation factors, it is
likely that the additional factors may stimulate internal initi-
ation of translation following the assembly of RNA-40 S com-
plex. Recently, binding of a 25-kDa cellular protein (p25) to
HCV IRES has been shown to be important for the efficient
translation initiation. p25 was originally suggested to be ribo-
somal protein S9 but later identified as rpS5 (14, 17, 18). In
fact, HCV IRES has been suggested to have a prokaryotic-like
mode of interaction with the 40 S ribosomal subunit, where the
40 S ribosomal subunit is thought to interact with the HCV-
IRES through p25 (14). However, eukaryotic mRNAs and pi-
cornaviral IRESs have not been reported to require S5 protein
for the ribosome assembly. Recently we have shown that a
small RNA corresponding to the stem-loop III ef domain of
the HCV IRES, when introduced in trans, can antagonize cel-
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lular protein binding to the viral IRES and inhibits HCV IRES-
mediated translation. The RNA molecule showed strong inter-
action with the ribosomal S5 protein and prevented the
recruitment of the 40 S ribosomal subunit by the HCV IRES
(19). Therefore, it appears that any event that might facilitate
S5 interaction with HCV IRES could be crucial for efficient
ribosome assembly at the initiation site. It is believed that HCV
IRES contains one set of determinants that is required for
initial ribosome recruitment and a second set that promotes
accurate placement of the initiation codon in the ribosomal P
site (13). Several cellular trans-acting factors that are known to
bind to HCV IRES and influence the internal initiation might
play a role in the formation of functional initiation complex
after the initial binding of 40 S ribosomes to the IRES. Most
notable among these are the polypyrimidine tract-binding pro-
tein (PTB), (20) the La autoantigen (21), and poly(rC) binding
protein 2 (PCBP 2) (22) etc. In case of picornaviruses, a model
has been proposed in which the IRES trans-acting factors such
as PTB help the RNA to attain or maintain an active confor-
mation in which it is able to bind essential factors and the 43 S
ribosome complex in a productive manner (23). In hepatitis A
virus, glyceraldehyde-3-phosphate dehydrogenase was found to
destabilize the folded structures of the RNA stem-loops and
influence the IRES activity (24). Human La autoantigen was
found to enhance the accuracy of initiation codon selection in
poliovirus IRES (25).
The human La protein is an RNA-binding protein, belonging
to the RNA recognition motif (RRM) superfamily (26, 27). La
protein is ubiquitously expressed in many eukaryotic organ-
isms, including Saccharomyces cerevisiae, Xenopus laevis, and
Drosophila melanogaster (28). La protein has been shown to
interact with a wide variety of cellular and viral RNAs and has
been implicated in various cellular processes, which include
RNA polymerase III transcription termination (27), telomere
homeostasis (29), internal initiation of translation of Bip
mRNA, poliovirus, coxsackievirus B3, encephalomyocarditis
virus, and hepatitis C virus (30, 31). Also, La protein has been
shown to be capable of unwinding DNA-RNA hybrids and dou-
ble-stranded RNA in an ATP-dependent manner (32). La pro-
tein specifically interacts with both the 5- and 3-UTR of HCV
RNA (33). La protein plays a functional role in internal initia-
tion of translation where addition of purified La to RRL in the
in vitro translation assays using HCV IRES resulted in stim-
ulation of translation activity (21). Inhibition of HCV IRES
activity caused by sequestration of La protein can be rescued by
exogenous addition of purified La protein (34, 35).
Previously, La protein has been shown to bind to HCV IRES
in the context of initiator AUG (21). Recently, we showed that,
of the three RRMs present in La, RRM2 binds HCV RNA
around the region encompassing the GCAC motif located in the
stem region near the initiator AUG (36). However, the precise
mechanism with which the La protein influences the stimula-
tion of HCV IRES activity is yet to be elucidated. Here we
report for the first time a possible functional role of La protein
interaction near the initiator AUG of the HCV-IRES RNA to
mediate efficient internal initiation of translation. We have
demonstrated that mutations in the GCAC motif near initiator
AUG within the SL IV, which alter the primary sequence while
retaining the overall secondary structure affect the binding of
La-RRM2 to HCV IRES. Also, these mutations have drastic
effect on the HCV IRES-mediated translation both in vitro and
in vivo, indicating that the sequence GCAC might play an
important role in maintaining the IRES function. Further, we
have observed that the mutations also alter the binding of
certain cellular proteins to HCV IRES, especially p25 (S5),
whose binding may have been influenced by the binding of La
protein to HCV IRES in the SL IV region. Interestingly, addi-
tion of increasing concentration of La protein helped in the
binding of S5 protein suggesting that La protein might play a
role in recruitment of the 40 S ribosomal subunit to the HCV
IRES RNA. Additionally, the circular dichroism spectra of HCV
stem-loop IV RNA showed a dose-dependent increase in the
presence of increasing concentrations of La protein indicating
that HCV IRES may undergo some conformational alterations
upon binding to La protein, which assist in the formation of
functional initiation complex. Finally, sucrose gradient centrif-
ugation analysis of ribosome assembly implied that the muta-
tions within HCV IRES lead to reduced efficiency in the for-
mation of functional ribosomal complex. Taken together, the
results strongly suggest that La protein interaction near the
initiator AUG might be involved in conformational alteration to
facilitate better contact with the 40 S ribosomal subunit re-
quired for efficient internal initiation of translation.
EXPERIMENTAL PROCEDURES
Plasmids—HCV 1b-encoding plasmid, pCV, was generously gifted by
Dr. Akio Nomoto and Dr. Tsukiyama-Kohara, University of Tokyo,
Japan. HCV 5-UTR along with 42-nt coding sequence (18–383 nt) was
cloned into the mammalian expression vector pcDNA3 (Invitrogen) to
generate pcDHCV-383 as described earlier (36). pcD-SL IV containing
nt 293–383 of HCV IRES was obtained by amplifying HCV SL IV using
the primers, 5-ATAGAAGCTTGCCTGATAGGTCTGCGA-3 and 5-C-
GCGAATTCGTTACGTTTGGTTTT-3, from the template plasmid pc-
DHCV-383 and cloned between HindIII and EcoRI sites of the pcDNA3.
The PCRs were carried out with 30 cycles, each cycle consisting of
denaturation (95 °C for 40 s), annealing (55 °C for 1 min), and extension
(68 °C for 1 min/1 kb) using Pfx DNA polymerase (Invitrogen). The
cDNA clone encoding human La autoantigen, pET-La was obtained
from Dr. Jack Keene, Duke University. La coding sequence and La
101–208 (RRM2) were subcloned into pRSET-A vector (Invitrogen) (36).
Ribosomal protein S5 containing plasmid pQE-RS5 was obtained from
Dr. Shuetsu Fukushi, Biomedical Laboratories, Japan. S5 coding se-
quence was obtained from the vector by digesting with HindIII and
BamHI and subcloned into pRSET-A vector.
All the mutants described in the study were generated by using a
megapriming PCR method as described previously (37). The method
utilizes three oligonucleotide primers to perform two rounds of PCR.
The product of the first PCR is used as one of the primers (a “mega-
primer”) for the second polymerase chain reaction. The first round of
PCR was carried out using the 3 primer corresponding to 383 nt of
HCV RNA, 5-CGCGAATTCGTTACGTTTGGTTTT-3, and the
following 5 primers carrying the specific mutations, 5-CCGTGCATC-
AAGAGCACAAAT-3, 5-TCGTAGACCACTAATCATGATAGTAAATC-
CTAA-3, and 5-TCGTAGACCCGGTATCATGAACCGAAATCCTAA-
3. The PCRs were carried out for 35 cycles, each cycle consisting of
denaturation (95 °C for 40 s), annealing (55 °C for 1 min), and extension
(72 °C for 10 s) using TaqDNA polymerase (Bangalore Genie) or Pfx
polymerase. The amplification products were subjected to 9% native
PAGE and visualized by staining with ethidium bromide. The bands
were cut and incubated in 400 l of elution buffer (0.5 M ammonium
acetate, 10 mM magnesium acetate, 0.1% SDS) overnight at 37 °C. The
supernatant was subjected to phenol-chloroform extraction, and the
DNAs were alcohol-precipitated. The megaprimers thus obtained were
then used as 3 primers in the second round of PCR along with the HCV
5 primer, 5-TATAAGCTTGGATCCCCGGCGACA-3. The PCRs were
carried out for 35 cycles, each cycle consisting of denaturation (95 °C for
40 s), annealing (60 °C for 1 min), and extension (72 °C for 30 s) using
TaqDNA polymerase or Pfx polymerase. The PCR products were di-
gested with HindIII and EcoRI and cloned into pcDNA3 vector. pcD-SL
IV M4mut was generated using the primers 5-ATAGAAGCTTGCCT-
GATAGGGTGCTTGCGA-3, 5-CGCGAATTCGTTACGTTTGGTTTT-
3, using the plasmid M4 as template and cloned between HindIII and
EcoRI sites of the pcDNA3.
For the construction of bicistronic constructs, the two reporter genes,
Renilla luciferase (RLuc) and Firefly luciferase (FLuc) coding sequences
were PCR-amplified using Pfx polymerase using the following primers,
5-GCATGCTAGCACCATGACTTCGAAA-3, 5-GGCCAAGCTTACCA-
TGATTCGAAA-3, 5-GCATCTCGAGGAAGACGCCAAAAAC-3, and
5-ATTAGGGCCCTTACACGGCGATCTT-3. The 5 primer of FLuc
lacks the initiator AUG codon, because the HCV IRES has an initiator
AUG located within. The amplified RLuc was cloned into NheI and XhoI
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sites of pcDNA3.1 () vector (Invitrogen), and FLuc was cloned into
XhoI and ApaI sites. The wild-type and mutant HCV IRES were cloned
into HindIII and EcoRI sites between the two reporter genes.
Preparation of HeLa S10 Cell Extract—HeLa cells used for preparing
cell extract were grown in T75 flasks in minimal essential medium (pH
7.0) supplemented with 10% fetal calf serum. Monolayer of HeLa cells
were harvested, pelleted down, and washed thrice with cold isotonic
buffer (35 mM HEPES, pH 7.4, 146 mM NaCl, 11 mM glucose), resus-
pended in 1.5 packed cell volume of hypotonic buffer (10 mM HEPES,
pH 7.4, 15 mM KCl, 1.5 mM magnesium acetate, and 6 mM -mercap-
toethanol) and then incubated on ice for 10 min. Cells were then
transferred to a Down’s homogenizer and disrupted by 50 strokes on ice
(lysis was checked under microscope). The lysate was incubated in 1
incubation buffer for 10 min. Cytoplasmic extract (S10 supernatant)
was isolated by centrifuging the lysate at 10,000  g for 30 min at 4 °C.
The supernatant was dialyzed for 4 h against 100 volumes of dialysis
buffer and aliquoted into pre-chilled tubes. The aliquots of S10 extract
were stored at 70 °C.
Purification of rpS5, La Full-length, and RRM2 Proteins Using a Nick-
el-Nitrilotriacetic Acid-Agarose Column—Escherichia coli BL21(DE3)
cells were transformed with pRSET-A vectors containing either the full-
length or the deletion mutant of La or the full-length rpS5. Transformed
colonies were inoculated into 100 ml of LB broth containing 75 g/ml
ampicillin and grown at 37 °C in an incubator shaker at 200 rpm speed
until the OD660 reached 0.6. The cultures were induced with 0.6 mM
isopropyl-1-thio--D-galactopyranoside and grown for further 4 h. The
cells were pelleted and resuspended in 5 ml of lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole). The extract was made by
sonication. The above crude extracts were mixed with 500 l of nickel-
nitrilotriacetic acid-agarose slurry (Qiagen) and kept for rocking at 4 °C
for 4 h. The lysate was loaded onto a column, and the flow-through was
discarded. The column was washed with 50 ml of wash buffer (50 mM
NaH2PO4, 300 mM NaCl, 40 mM imidazole). The bound protein was eluted
with 500 l of elution buffer containing 500 mM imidazole. The eluted
proteins were dialyzed at 4 °C for 4–6 h in 500 ml of dialysis buffer (50 mM
Tris (pH 7.4), 100 mM KCl, 7 mM -mercaptoethanol, 20% glycerol),
aliquoted, and stored in 70 °C freezer.
In Vitro Transcription—mRNAs were transcribed in vitro from dif-
ferent linearized plasmid constructs under T7 promoters in run-off
transcription reactions. The HCV bicistronic constructs were linearized
with PmeI downstream of firefly luciferase and used as templates for
RNA synthesis. The linear DNA were electrophoresed on agarose gels
and extracted by using Qiagen gel elution kit and capped bicistronic
RNA were synthesized using Ribomax Large scale RNA production
system-T7 (Promega) under standard conditions with addition of 5 cap
analog (Promega).
Radiolabeled mRNAs were transcribed in vitro using T7 RNA polym-
erase (Promega) and [32P]uridine triphosphate (PerkinElmer Life Sci-
ences). The pcDNA3 vectors containing wild-type or mutant HCV IRES
were linearized with EcoRI, gel-eluted, and transcribed in vitro to
generate the 32P-labeled RNA. The transcription reaction was carried
out under standard conditions (Promega protocol) using 2.5 g of linear
template DNA at 37 °C for 1.5 h. After alcohol precipitation, the RNA
was resuspended in 25 l of nuclease-free water. 1 l of the radiolabeled
RNA sample was spotted onto DE81 filter paper, washed with phos-
phate buffer, and dried, and the incorporated radioactivity was meas-
ured using liquid scintillation counter.
Filter Binding Assay—The 32P-labeled wild-type or mutant HCV
IRES RNAs were incubated with the La RRM2 or RRM3 proteins at
30 °C for 15 min in RNA binding buffer (containing 5 mM HEPES, pH
7.6, 25 mM KCl, 2 mM MgCl2, 3.8% glycerol, 2 mM DTT, and 0.1 mM
EDTA) and loaded onto nitrocellulose filters equilibrated with the 2-ml
RNA binding buffer. The filters were then washed four times with 1 ml
of binding buffer and air-dried. The counts retained were measured in
liquid scintillation counter. The graph was plotted with protein concen-
tration (micromolar) on the x-axis, and the percentage of bound RNA
was plotted as the percentage of counts retained, on the y-axis.
UV Cross-linking Experiment—The 32P-labeled wild-type or mutant
HCV IRES RNAs were incubated with the purified proteins or HeLa
S10 extract at 30 °C for 15 min in RNA binding buffer (containing 5 mM
HEPES, pH 7.6, 25 mM KCl, 2 mM MgCl2, 3.8% glycerol, 2 mM DTT, and
0.1 mM EDTA) and then irradiated with a hand-held UV lamp for 10
min. The mixture was treated with 30 g of RNase A (Sigma) at 37 °C
for 30 min. The protein-nucleotidyl complexes were electrophoresed on
SDS-10% PAGE analyzed by phosphorimaging analysis. In the experi-
ments performed in the presence of La protein, the RNA was incubated
with the purified proteins at 30 °C for 10 min prior to binding with
HeLa S10 extracts.
In Vitro Translation—In vitro translation of the capped bicistronic
mRNAs were carried out in micrococcal nuclease treated rabbit reticu-
locyte lysates (RRL, Promega Corp.). Briefly, 12.5-l reaction mixtures
contained 8.75 l of RRL containing 0.25 l each of minus methionine
mixture, 5 Ci of [35S]methionine (PerkinElmer Life Sciences) and 10
units of RNasin (Promega) were incubated at 30 °C for 1.5 h. 1 l of the
reaction mixtures was assayed for both the Renilla and firefly luciferase
activity according to Promega protocol using Dual-Luciferase reporter
assay system. 7 l of the reaction mixtures was electrophoresed on
SDS-10% polyacrylamide gel, dried, and analyzed by phosphorimaging.
Transfection of HeLa/Huh7 Monolayer Cells—HeLa/Huh7 cells
grown in 30-mm dishes at 60–70% confluence were transfected with 2
g of the bicistronic constructs using Tfx 20 transfection reagent (Pro-
mega) according to manufacturer’s protocol. Briefly, the DNA was
mixed with 5 l of Tfx 20 reagent and diluted to 1 ml using the MEM
(Invitrogen) and incubated at room temperature for 15 min. The cells
were washed with medium and overlaid with 1 ml of MEM containing
the above DNAs. After 1 h of incubation at 37 °C, 0.8 ml of MEM, and
0.2 ml of fetal bovine serum (Invitrogen) was added to the dishes. After
36 h, the cells were washed with phosphate-buffered saline and lysed
using 1 passive lysis buffer (Promega) and assayed for RLuc and FLuc
according to Promega protocol using the Dual-Luciferase reporter assay
system.
CD Spectroscopy—Measurements of CD spectra were performed with
a Jasco J-715 spectropolarimeter as described earlier (38). Spectra were
obtained in 0.5 ml of RNA binding buffer (5 mM HEPES, pH 7.6, 25 mM
KCl, 2 mM MgCl2, 3.8% glycerol, 2 mM DTT, 0.1 mM EDTA). CD spectra
were obtained in the 240- to 320-nm range at 20 °C with HCV stem-loop
IV WT or stem-loop IV M4 RNA (250 or 300 nM) and increasing con-
centration of purified recombinant La protein (0.5–2 M). The molar
ellipticity values were normalized for the contribution of the La protein
at each concentration.
Sucrose Gradient Centrifugation Analysis of Ribosomal Assembly on
HCV IRES—The 32P-radiolabeled RNAs (2  105 cpm) were added to
50 l of ribosome assembly reactions containing 35 l of RRL, 0.5 l
each of minus methionine and minus leucine amino acid mixtures and
10 units of RNasin (Promega) and incubated at 30 °C for 15 min. The
reactions were diluted to 150 l with gradient buffer (20 mM Tris (pH
7.5), 100 mM KCl, 3 mM MgCl2, 1 mM DTT) and overlaid on a 5–30%
(w/v) linear sucrose gradient. The ribosomal complexes were sedi-
mented by ultracentrifugation for 3 h at 4 °C and 30,000 rpm using a
Beckman SW41 swing bucket rotor. Fractions (5 drops) were manually
collected from the bottom of the tube and counted in a Rackbeta liquid
scintillation counter.
RESULTS
Mutations at the GCAC Motif Near Initiator AUG in Stem-
loop IV of HCV IRES Affect Binding to RRM2 of La Pro-
tein—We have demonstrated earlier that the RRM2 of human
La protein binds to hepatitis C virus IRES in the region en-
compassing GCAC motif near the initiator AUG located in
stem-loop IV. Interestingly, we have also noticed that this
GCAC sequence motif is relatively conserved across the geno-
types of HCV (data not shown). Thus it was interesting to
investigate whether the binding of RRM2 of La protein to HCV
RNA in this region influences the IRES-mediated translation.
Several mutations in SL IV were designed in such a way as to
alter the primary nucleotide sequence of the GCAC motif,
whereas the compensatory mutations in the other strand would
allow the secondary structure to be retained (Fig. 1A). Two
mutants, M1 and M2, were generated in the GCAC region,
either altering the GC content (M1) or retaining it (M2) and
confirmed by sequencing. Interestingly, during the sequencing
of the above clones we also found two more mutant clones that
harbored an additional mutation, C325U (at the beginning of
the pseudoknot) along with the designed mutations in SL IV
region. Consequently these additional mutants were named as
M3 and M4 (Fig. 1A). To investigate the contribution of this
additional mutation at the 325 position, we have generated one
more mutant with substitution at this position, C325U (named
as M6). Earlier studies from other laboratories have indicated
the importance of La binding at the initiator AUG, hence we
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also generated another mutant M5 where AUG was substi-
tuted with AAG, to use as a control in our studies.
To study the effect of mutations in the SL IV region of the
HCV IRES RNA on binding to La-RRM2 protein, filter binding
assays were performed. The 32P-labeled wild-type or mutant
HCV IRES RNAs were incubated with the increasing concen-
FIG. 1. Effect of mutations in SL IV on binding to La-RRM2 and La-RRM3 proteins. A, schematic representation of the predicted
secondary structure of HCV IRES indicating the stem-loops (adapted from Brown et al. (6)). The positions of the mutations are highlighted in the
magnified SL IV region. B, filter binding assay to study the binding of HCV wild-type and mutant IRES with La-RRM2 and RRM3. The 32P-labeled
wild-type or mutant HCV IRES RNAs, M1–M6 (as indicated by the symbols to the right of the panel), were bound to increasing concentrations of
either La-RRM2 or La-RRM3 proteins. The amount of bound RNA was determined by binding to the nitrocellulose filters. The percentage of bound
RNA was plotted against the protein concentration (micromolar).
La Protein Binding to HCV SL IV Facilitates Ribosome Assembly29882
 by guest, on Decem
ber 22, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
tration of purified recombinant La-RRM2 protein (0.5 and 0.75
M). The amount of bound RNA was determined by binding to
nitrocellulose filters followed by plotting to obtain the satura-
tion curve. RRM2 showed efficient binding with the wild-type
HCV IRES RNA. All the four mutants with mutations in GCAC
sequence (M1, M2, M3, and M4) showed a significant reduction
in their ability to bind to RRM2 to different extents (between 70
and 90%). However, the mutants M2, M3, and M4 showed
much more drastic effect on the binding ability compared with
the mutant M1. Interestingly, the single mutant M6 (C325U)
did not show significant reduction in binding to RRM2 indicat-
ing that this mutation alone may not contribute to the reduc-
tion in binding ability, but along with the mutations at GCAC
motif, may result in pronounced effect. As expected, the M5
mutant, where initiator AUG was mutated, showed a drastic
decrease in binding to La-RRM2. As a control, when the same
experiment was performed with La RRM3 protein, it was ob-
served that the binding of the HCV IRES was not affected due
to the mutations in stem-loop IV. The result was consistent
with our earlier observation that RRM2 indeed binds at the
GCAC near the initiator AUG and RRM3 binds to HCV IRES at
regions other than this RRM2 binding site. When RNA toe-
printing assay was performed using the mutant M4 RNA and
La protein, no toe-prints were detected corresponding to the
GCAC, as obtained with the wild-type HCV IRES RNA (data
not shown). The result further confirmed the observations
made from the filter-binding experiments.
Mutations in Stem Loop IV Region That Affect the Binding to
La-RRM2 Results in Reduced IRES-mediated Translation in
Vitro—Human La protein interaction with the HCV IRES has
been shown to be critical for mediating internal initiation of
translation. Previously we have shown that La protein interacts
with the HCV IRES near the initiator AUG through RRM2. To
study the effect of mutations in HCV IRES that abrogate RRM2
interaction, an in vitro translation experiment has been per-
formed. Because the mutants M3 and M4 showed almost total
abrogation of the ability to interact with RRM2, these mutants
were used for further studies. Additionally as a negative control
AUG mutant, M5 was included in the experiment. To compare
the translation efficiencies of mutants to that of wild-type, in
vitro transcribed capped bicistronic RNAs containing two re-
porter genes, Renilla luciferase (RLuc) and firefly luciferase
(FLuc) flanked by either wild-type or mutant HCV IRES were
assayed for translation activity in rabbit reticulocyte lysate
(RRL). In the bicistronic RNAs, translation of first cistron, RLuc
occurs in cap-dependent manner while FLuc translation is me-
diated by the HCV IRES. To avoid alternative initiation site, the
initiator AUG was deleted from the second cistron, FLuc, such
that initiation takes place at the initiator AUG located within the
SL IV of the HCV RNAs. Half of the reaction mixtures were
electrophoresed on SDS-10% PAGE and analyzed by phospho-
rimaging. Lane C represents the translation from HCV wild-type
bicistronic RNA, showing the efficient translation of both the
reporter genes, RLuc and FLuc. Lane M5 represents AUG mu-
tant bicistronic RNA, used as a negative control, where the trans-
lation of second cistron FLuc was totally abrogated. Lanes M3
and M4 represent the mutant bicistronic RNA where the trans-
lation of FLuc was found to be highly impaired (Fig. 2A). Alter-
natively, to quantitate the translation products, the luciferase
activities were measured from the reaction mixtures using dual
luciferase assay system (Promega). The ratio of FLuc to RLuc
activities was calculated in case of each bicistronic RNA for
normalization. The translation activities of mutant RNAs were
plotted as a percentage to that of wild-type RNA. Both the mu-
tants, M3 and M4, showed pronounced effect on the HCV IRES-
mediated translation (Fig. 2B). However, mutant M4 showed
marginally more inhibition as compared with M3. The control
AUG mutant did not show any FLuc translation as expected.
Additionally, when the in vitro translation experiments were
repeated with mutant RNAs M1 and M2, significant translation
inhibition was observed (data not shown). The results suggest
that the binding of La protein through the RRM2 in the SL IV
region of HCV IRES might play a critical role in internal initia-
tion of translation.
Mutations in the HCV Stem-loop IV Had a Drastic Effect in
Mediating Internal Initiation of Translation in Vivo—The re-
sults of in vitro translation in RRL indicated that the muta-
tions in SL IV reduced the HCV IRES activity. To verify the
results of the in vivo conditions, the bicistronic construct DNAs
were transiently transfected into mammalian monolayer cells.
Because it was earlier shown that HeLa and Huh 7 (liver-
derived) cell lines support efficient translation by HCV IRES,
both these cell lines were used for comparing the translation
efficiency of the mutants with the wild-type HCV IRES. 60–
70% confluent monolayer cells were transfected with an equal
amount of wild-type or mutant bicistronic constructs using Tfx
20 transfection reagent (Promega). 36 h post-transfection, the
cells were lysed, and the extracts were used to measure lucif-
erase activities using the Dual-Luciferase assay system (Pro-
mega). The transfection efficiency was normalized by taking
the FLuc/RLuc ratio for each bicistronic construct. The AUG
mutant bicistronic construct, M5, did not show any FLuc ac-
tivity due to the lack of functional initiation codon for the
FIG. 2. Effect of mutations in SL IV in HCV IRES mediated
translation in vitro. A, 1 g of wild-type and mutant capped HCV
bicistronic constructs were translated in rabbit reticulocyte lysate
(RRL), and the products were analyzed on SDS-10% polyacrylamide
gel followed by phosphorimaging. Renilla luciferase (RLuc) and fire-
fly luciferase (FLuc) products are indicated by arrows. Lane M rep-
resents the mobility of the 14C protein molecular weight marker. The
corresponding molecular masses are indicated to the left of the panel.
Wild-type (C) and mutant (M3–M5) bicistronic RNAs used in the
translation reactions are indicated at the top of the lanes. B, both the
reporter genes, Renilla luciferase (RLuc) and firefly luciferase (FLuc)
activities were measured by Dual-Luciferase assay (Promega). The
ratio of FLuc to RLuc activity representing the efficiency of wild-type
bicistronic RNA (C) and the mutants (M3–M5) were plotted. The
relative FLuc activities of the mutants were represented as a per-
centage of the control reaction (expressed as 100%). Results represent
an average of three independent experiments.
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second cistron. Consistent with the in vitro results, in the case
of mutants M3 and M4, translation efficiency was reduced up
to 90% as compared with the wild-type IRES (Fig. 3). Similar
results were obtained in the case of both the cell types, HeLa
(Fig. 3A) and Huh 7 (Fig. 3B), ruling out any cell-type-specific
effect in the IRES activity. The results suggest that the muta-
tions at the GCAC motif in the SL IV reduced the efficiency of
the HCV IRES-mediated translation in vivo.
Mutations in the GCAC Motif in Stem-loop IV Affect Cellular
Protein Binding to HCV IRES—HCV IRES is known to bind
several cellular proteins, including canonical initiation factors
and non-canonical trans-acting factors. These include polypyri-
midine tract-binding protein (PTB), human La autoantigen
(La), poly(rC)-binding protein (PCBP), heterogenous nuclear
ribonucleoprotein L, ribosomal protein factors, S5, and others.
To investigate if cellular protein binding is affected due to the
mutations in SL IV, UV cross-linking experiments were per-
formed with HeLa S10 cytoplasmic extract using wild-type and
mutant HCV IRES RNAs. The 32P-labeled RNAs were incu-
bated with HeLa S10 extract in binding buffer and cross-linked
by UV irradiation. After digesting the unbound RNA with
RNase A, the reactions were electrophoresed on SDS-polyacryl-
amide gels and analyzed by phosphorimaging. Although the
overall protein binding profiles between wild-type and mutant
HCV IRES RNA were very similar, the most notable difference
was noticed in the binding of a 25-kDa protein (p25). Mutations
in SL IV totally abrogated the binding of p25 to mutants M3
and M4 (Fig. 4). Similarly, when mutants M1 and M2 were
used, binding to p25 was affected, whereas mutant M6 (C325U)
did not affect the p25 binding (data not shown).
La Protein Facilitates the Binding of Ribosomal Protein S5 to
HCV IRES RNA—Because we have observed that binding of
cellular protein p25 was altered with the mutant RNAs, it was
interesting to investigate whether La protein binding to HCV
IRES RNA somehow facilitates interaction of p25 protein. To
address this, the wild-type HCV RNA was first incubated with
increasing amounts of purified recombinant La protein (50,
100, 200, and 300 ng) followed by incubation with HeLa S10
extract. Interestingly, it was observed that, with the addition of
recombinant exogenous La protein, there was dose-dependent
increase in the binding of a 25-kDa protein (p25). Recombinant
La protein also competed with the endogenous La (p52) for the
binding as apparent from the dose-dependent decrease in p52
band intensity and increase in the band corresponding to the
recombinant La protein. Some other protein binding also
seemed to be affected along with the p52 binding suggesting
that La protein might influence interaction of other cellular
proteins as well (Fig. 5A). Earlier, the 25-kDa protein (p25)
that interacts with HCV IRES has been identified as ribosomal
protein S5 (rpS5). The S5 protein binding to HCV IRES has
been shown to be crucial for the 40 S interaction. To investigate
whether La protein assists the binding of S5 to HCV IRES,
recombinant purified S5 protein was bound to HCV IRES in the
absence or presence of increasing concentrations of recombi-
nant La protein (100, 200, and 300 ng, respectively). Exogenous
addition of recombinant La protein was found to influence the
binding of S5 to HCV IRES significantly as apparent from the
dose-dependent increase in band intensity of recombinant S5
(Fig. 5B). Thus the observations strongly suggest that the
binding of La protein is important for the binding of S5 protein,
which in turn might influence the ribosome assembly for effi-
cient translation initiation activity of the HCV IRES RNA.
FIG. 3. Translational abilities of SL IV mutants in transient
transfection analysis. A and B, 2 g of plasmid DNAs containing
wild-type or mutant HCV bicistronic constructs were transiently trans-
fected into HeLa (Panel A) or Huh 7 (Panel B) monolayer cells. 36 h
post-transfection, the expression of FLuc and RLuc from the constructs
was assayed by Dual-Luciferase assay (Promega). The ratio of FLuc to
RLuc activity representing the efficiency of wild-type bicistronic con-
struct (C) and the mutants (M3–M5) were plotted. The relative FLuc
activities of the mutants were represented as a percentage of the control
reaction (expressed as 100%). The results represent an average of three
independent experiments.
FIG. 4. Effect of mutations in HCV SL IV on cellular protein
binding. The 32P-labeled wild-type and mutant HCV IRES RNAs (as
described above the panel) were UV cross-linked to HeLa S10 cytoplas-
mic extract, digested with RNase A, and resolved by SDS-10% PAGE
followed by phosphorimaging. Positions of p25 and p52 are indicated.
Lane M represents 14C protein molecular weight marker. The corre-
sponding molecular masses are indicated to the left of the panel.
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Binding of La Protein to Stem-loop IV of HCV IRES Leads to
Conformational Alterations within the RNA—Our results sug-
gested that perhaps interaction of La protein through RRM2 at
the GCAC motif near initiator AUG facilitates 40 S ribosomal
binding through S5. Thus, to further investigate if interaction
of La protein at this region brings about any conformational
alterations within the HCV IRES, which would favor the 48 S
ribosome assembly, the CD spectra of HCV RNA was analyzed
in the absence and presence of purified recombinant La pro-
tein. CD spectra were obtained in the 240- to 320-nm range at
20 °C with stem-loop IV of HCV wild-type RNA (250 nM) in 0.5
ml of RNA-binding buffer. The CD spectrum of the SL IV RNA
was characterized by a signature band centered at 268 nm that
increases in magnitude upon incubation with increasing con-
centration of purified recombinant La protein (0.5–2 M). The
molar ellipticity values were minimal for the La protein at
wavelengths above 240 nm, however, the values were still
normalized for the contribution of the La protein at each con-
centration. The molar ellipticity value of SL IV RNA increased
significantly (Fig. 6A) upon incubation with La protein indicat-
ing that the protein binding was inducing certain conforma-
tional alterations within the RNA. When a similar experiment
was performed using mutant RNA, corresponding to SL IV of
M4, no significant change was observed in the CD spectrum of
the RNA upon incubation with the La protein (Fig. 6B). How-
ever, UV cross-linking studies revealed that both wild-type SL
IV and mutant SL IV do bind to La protein (data not shown),
thus ruling out the possibility that the altered molar ellipticity
values were simply due to RNA-protein interaction. The results
indicated that the effect of La protein was specific for the
wild-type HCV SL IV RNA and not for the mutant SL IV RNA.
Mutations in the Stem-loop IV Affect the Ribosomal Assembly
on HCV IRES RNA—UV cross-linking experiments showed
that the mutations at the GCAC in HCV IRES RNAs affected
the interaction with S5 ribosomal protein. Also, from our study,
it appears that La binding near the GCAC at the SL IV region
results in conformational alterations in the RNA, which might
facilitate the ribosome assembly at the initiation site. Thus it
was interesting to investigate if the lack of interactions of
La-RRM2 and S5 proteins at this region could affect the func-
tional ribosome complex formation near the initiator AUG of
HCV IRES RNA. For the purpose, sucrose gradient centrifuga-
tion experiments were performed, followed by the analysis of 48
S and 80 S ribosomal peaks. The 32P-labeled wild-type and
mutant HCV IRES RNAs were incubated in translation reac-
tions containing RRL and amino acid mixture and loaded onto
5–30% sucrose gradient and ultracentrifuged for 3 h at 30,000
FIG. 5. La protein binding helps in the interaction of riboso-
mal protein S5 to HCV IRES RNA. A, 32P-labeled HCV IRES RNA
was UV cross-linked to HeLa S10 extract in the absence (lane 1) or
presence of increasing concentrations of recombinant purified La full-
length protein (lanes 2–5). The reactions were treated with RNase A,
resolved on SDS-10% PAGE, and analyzed by phosphorimaging. Lane
M shows 14C protein molecular weight marker. The corresponding
molecular masses are indicated to the left of the panel. Positions of p25,
p52, and recombinant-La (r-La) are indicated to the right. Other protein
bands, which showed altered intensities upon addition of La protein,
are indicated with asterisks. B, wild-type 32P-labeled HCV IRES RNA
was UV cross-linked to recombinant purified S5 protein in the absence
(lane 2) or presence of increasing concentrations of recombinant puri-
fied La protein (lanes 3–5). Lanes 6 shows binding of highest concen-
tration of La protein to HCV IRES in absence of S5. Lane 1 is no protein
control. The bands corresponding to La and S5 protein obtained from
the same gel are represented separately for clarity. The mean band
intensity of the S5 band corresponding to each lane (as indicated) was
quantitated by phosphorimaging analysis and graphically represented
below the panel.
FIG. 6. Analysis of CD spectra of wild-type and mutant HCV SL
IV RNA in absence and presence of increasing concentration of
La protein. A and B, CD spectra were obtained in 0.5 ml of RNA-binding
buffer between 240- and 320-nm wavelength range at 20 °C with stem-
loop IV of HCVWT (panel A) or stem-loop IV of mutant RNA (correspond-
ing to M4) (panel B), in the absence or presence of increasing concentra-
tion of purified recombinant La protein (0.5–2 M). The molar ellipticity
values were normalized for the contribution of the La protein at each
concentration. Symbols in each curve corresponding to the concentration
of La protein used are indicated to the right of the panels.
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rpm. The fractions were collected from the bottom of the tube,
and scintillation counts were measured. The percentage of
counts in each fraction was plotted against the fraction volume
of the gradient. When wild-type HCV IRES RNA was used, two
peaks were observed in equilibrium, corresponding to 80 S and
48 S ribosomes associated with the labeled HCV RNA (Fig. 7A).
When AUG mutant RNA (M5) was used, the peaks correspond-
ing to 80 S ribosomes were not observed while the 48 S ribo-
somes were found to be associated with the RNA indicating
that functional initiation AUG codon is essential for association
of 60 S ribosomal subunit in the 80 S complex (Fig. 7D). Addi-
tion of cycloheximide resulted in the increase in 80 S peak due
to the trapping of 80 S ribosomal complexes on the RNA (Fig.
7F). When the experiments were performed with either M3 or
M4 RNAs, we observed a marginal increase in 80 S peak,
whereas the 48 S ribosome peak was significantly reduced (Fig.
7, B and C). To verify if this effect was due to altered binding of
La protein to SL IV, we have taken help of an inhibitor RNA
(I-RNA) that was earlier shown to sequester La protein from
translation reactions and inhibit HCV IRES-mediated transla-
tion. When an excess of I-RNA (750-fold) was added to the
translation reactions using the wild-type HCV RNA, both the
48 S and 80 S peaks were reduced significantly (Fig. 7E).
Taken together, the results strongly suggest that the mu-
tations at the SL IV region affect the binding of La-RRM2 at
the GCAC near the initiator AUG, as a consequence of which
formation of functional ribosomal initiation complex is se-
verely affected and thus resulting in reduced HCV IRES-
mediated translation.
DISCUSSION
The ribosome assembly at the Hepatitis C virus IRES is
known to require minimal number of eukaryotic initiation fac-
tors. HCV IRES has been shown to be capable of binding
directly to purified small ribosomal subunit (40 S) with the help
of the ribosomal protein S5, followed by correct positioning on
to the initiator AUG (14, 18). It is possible that in the absence
of any canonical initiation factors, some additional cellular
trans-acting factors might also be involved in the formation of
functional initiation complex on the HCV IRES RNA.
Although, it has been known for a while that human La
protein binds to HCV IRES and helps in stimulation of HCV
IRES-mediated translation, the exact mechanism is yet to be
elucidated. Earlier we have demonstrated that La protein
might bind to the GCAC sequence motif present near the ini-
tiator AUG through its RRM2. It has been speculated that La
protein might mediate the unwinding of SL IV region in a way
that would facilitate the interaction of the 40 S ribosomal
subunit with the HCV IRES RNA (7). In this study the results
strongly support the hypothesis and demonstrate that indeed
La protein binding near the initiator AUG facilitates the inter-
actions with p25 (S5) and the 48 S ribosome assembly and
influence the functional initiation complex formation on the
HCV IRES RNA.
FIG. 7. Sucrose gradient centrifuga-
tion analysis of the ribosomal assem-
bly on the wild-type and mutant HCV
IRES RNAs. Sucrose gradient sedimen-
tation profiles of 32P-labeled wild-type
(panel A) or mutant (panels B–D) HCV
IRES RNAs after incubated in RRL and
separated on 5–30% sucrose gradient.
The fractions (5 drops) were manually col-
lected from the bottom of the tube, and
scintillation counts were measured. The
counts per minute of each fraction, shown
as percentage of the total counts added to
the reaction (2 105cpm) and were plot-
ted against the volume of the gradient
solution (0–8 ml). The ribosomal peaks
corresponding to 48 S and 80 S are indi-
cated. Panel E represents sedimentation
profile of wild-type HCV IRES RNA incu-
bated in RRL in the presence of 750-fold
excess of yeast inhibitor RNA (I-RNA),
and panel F represents the profile in the
presence of cycloheximide (500 g/ml).
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We have observed a direct correlation between the reduced
interaction of mutant RNAs with the La-RRM2 and their abil-
ity to mediate efficient internal initiation. The fact that mutant
M5, where AUG has been mutated, failed to bind RRM2 is
consistent with the earlier observation that the presence of
initiator AUG is important for La protein binding at the SL IV
region. Substantial decrease in binding of mutants M1 and M2
to La-RRM2 suggest that the GCAC sequences at SL IV stem
region might be important even in the presence of initiator
AUG. We ensured that the GCAC mutations are associated
with compensatory mutations in the other strand to maintain
the stem-structure within the SL IV region. Interestingly, mu-
tations upstream of this region such as C325U (M6 RNA) did
not affect the RRM2 interaction, although it might affect the
translation because of the disruption of the pseudoknot struc-
ture. In fact, it has been demonstrated that the maintenance of
this structural element is critical for internal initiation of
translation (39). La-RRM3 interaction was not affected with
any of these mutants and supports our earlier observation that
La-RRM3 is likely to bind regions other that GCAC at the SL
IV of the HCV IRES RNA.
We have observed that the mutations also alter the binding
of certain cellular proteins to HCV IRES, whose binding may
have been influenced by the binding of La protein to SL IV
region. The effect on the cellular La protein interaction with
mutant RNAs was not apparent in the UV cross-linking exper-
iment; this could be due to the fact that the other La binding
sites were not altered. In fact, filter binding experiments dem-
onstrated that the mutations in SL IV resulted in a drastic
decrease in the binding of La-RRM2 to the HCV IRES, whereas
the La-RRM3 binding was unaffected. La protein might assist
the binding of other essential cellular factors to HCV RNA
either directly through protein-protein interactions or by me-
diating structural alterations of the RNA, which would facili-
tate the interaction with other trans-acting factors. One of the
proteins whose binding was drastically affected was found to be
p25 (S5). Interestingly, earlier it has been demonstrated that
the CAC triplet within the stem of domain IV region is pro-
tected in foot-printing experiments with HCV IRES and 40 S
complexes (40), which overlaps with the La-RRM2 binding site
as shown in this study. Hence, it is likely that La protein
binding to SL IV may have a role in positioning the S5 protein
onto HCV IRES. This is further confirmed by the observations
that mutations in SL IV, which reduced the binding to La-
RRM2 failed to alter the conformations of the IRES RNA,
which affected the interactions with S5 and thereby the forma-
tion of 48 S ribosome complexes. The possibility that La protein
might help in S5 interaction with HCV IRES RNA was further
supported by the observation that addition of increasing con-
centration of recombinant La protein showed dose-dependent
increase of p25/S5 protein interaction with HCV IRES. How-
ever, the effect was more pronounced in the presence of other
cellular proteins in HeLa S10. So, we do not rule out the
possibility that the other cellular proteins along with La pro-
tein might also be involved in facilitating the S5 interaction
with IRES.
La protein has been shown to have double-stranded RNA un-
winding activity (32). It is possible that La might help in unwind-
ing the stem structure that immediately follows the initiator
AUG and thus facilitate the advancement of initiation complex.
Earlier it was demonstrated that glyceraldehyde-3-phosphate
dehydrogenase, an IRES trans-acting factor, mediates conforma-
tional alterations of hepatitis A virus IRES RNA (24). Significant
increase in the CD spectra of HCV stem-loop IV RNA in the
presence of La protein was observed suggesting that RNA is
undergoing some conformational alterations upon binding to La
protein. However, it is not clear at this stage if the alterations in
the conformation are due to the secondary or tertiary level of
interactions. It is also possible that RNA unwinding of stem-loop
IV facilitates the movement of initiation complex. In fact, it has
been shown earlier that La protein interacts with DDX15/
hPrp43, which is a putative DEAH-box RNA helicase (41). Fur-
thermore, HCV RNA toe-printing analysis in the presence of
increasing concentrations of La protein revealed a decrease in
certain toe-prints corresponding to the RNA structure, which
suggests that La protein might help in melting some secondary
structures and facilitate the extension of the primer by the re-
verse transcriptase (Ref. 36 and data not shown).
Analysis of ribosome assembly on the mutant RNAs (M3 and
M4), indicates that the 40 S interaction is affected. This could
be due to reduced binding of the RNA with p25 as a conse-
quence of reduced La-RRM2 interaction at this site. The 80 S
peak was found to be marginally increased in the case of
mutant M3 and M4 RNAs. It appears that the initiation com-
plex was trapped, similar to what was observed in the presence
of cycloheximide. In contrast, addition of I-RNA resulted in
much more drastic effect in both the 48 S and the 80 S peaks.
I-RNA is known to sequester La protein and inhibit interaction
with all the binding sites on the HCV IRES, whereas M3 and
M4 mutations affect only La-RRM2 binding to the SL IV RNA
but the interaction with La-RRM3 remained unaltered.
Taken together, the study reveals the possible role of La
protein in unwinding of HCV IRES RNA structure to facilitate
the binding of 40 S ribosomal subunit through S5 ribosomal
protein and help in the formation of the functional initiation
complex to mediate efficient internal initiation of translation.
Future studies in an in vitro reconstituted system using iso-
lated components of the initiation complex will unfold the pre-
cise role of La protein in HCV IRES-mediated translation.
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